These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 6298381)

  • 1. Inhibition by dipyridamole of cerebral vasospasm induced in vitro by whole blood.
    Linder M
    J Neurosurg; 1983 Mar; 58(3):352-5. PubMed ID: 6298381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of whole blood-induced cerebral arterial contraction.
    Schumacher MA; Alksne JF
    Neurosurgery; 1981 Sep; 9(3):275-82. PubMed ID: 7301070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-activated protein kinase mediation of hemolysate-induced contraction in rabbit basilar artery.
    Zubkov AY; Ogihara K; Tumu P; Patlolla A; Lewis AI; Parent AD; Zhang J
    J Neurosurg; 1999 Jun; 90(6):1091-7. PubMed ID: 10350257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition and subsequent enhancement of platelet responsiveness by prostacyclin in the rabbit. Relationship to platelet adenosine 3',5'-cyclic monophosphate.
    Vanderwel M; Haslam RJ
    J Clin Invest; 1985 Jul; 76(1):233-40. PubMed ID: 2991338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral vasospasm: effects of prostaglandin synthetase inhibitors in vitro.
    Chapleau CE; White RP; Robertson JT
    Neurosurgery; 1980 Feb; 6(2):155-9. PubMed ID: 6767998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
    Oelz O
    Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study.
    Tobin WO; Kinsella JA; Collins DR; Coughlan T; O'Neill D; Egan B; Tierney S; Feeley TM; Murphy RP; McCabe DJ
    Br J Haematol; 2011 Mar; 152(5):640-7. PubMed ID: 21223254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dipyridamole and prostacyclin on rabbit platelet adherence in vitro and in vivo.
    Groves HM; Kinlough-Rathbone RL; Cazenave JP; Dejana E; Richardson M; Mustard JF
    J Lab Clin Med; 1982 Apr; 99(4):548-58. PubMed ID: 7038012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiaggregant therapy in cerebrovascular insufficiency in the aged].
    Fabris F; Pernigotti L
    Clin Ter; 1979 Jan; 88(1):21-31. PubMed ID: 35301
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of prostacyclin on cerebral vasospasm--an experimental study].
    Quintana L; Konda R; Ishibashi Y; Okada H; Suzuki J
    No Shinkei Geka; 1982 Oct; 10(10):1049-52. PubMed ID: 6757779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
    Violi F; Praticò D; Iuliano L; Balsano F
    J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipyridamole decreases protease-activated receptor and annexin-v binding on platelets of post stroke patients with aspirin nonresponsiveness.
    Serebruany V; Malinin A; Ziai W; Atar D; Pokov A; Jilma B; Hanley D
    Cerebrovasc Dis; 2006; 21(1-2):98-105. PubMed ID: 16340184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secondary prevention after stroke. 2 platelet inhibitors are better than one].
    MMW Fortschr Med; 2002 May; 144(19):61. PubMed ID: 12116558
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of prostacyclin and indomethacin on experimental delayed cerebral vasospasm.
    Fukumori T; Tani E; Maeda Y; Sukenaga A
    J Neurosurg; 1983 Nov; 59(5):829-34. PubMed ID: 6352874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipyridamole inhibits platelet aggregation in whole blood.
    Gresele P; Zoja C; Deckmyn H; Arnout J; Vermylen J; Verstraete M
    Thromb Haemost; 1983 Dec; 50(4):852-6. PubMed ID: 6665766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.